| Survival benefit of primary deceased donor transplantation with high-KDPI kidneys AB Massie, X Luo, EKH Chow, JL Alejo, NM Desai, DL Segev American journal of transplantation 14 (10), 2310-2316, 2014 | 249 | 2014 |
| Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series JL Alejo, J Mitchell, TPY Chiang, AT Abedon, BJ Boyarsky, RK Avery, ... Transplantation 105 (12), e280-e281, 2021 | 121 | 2021 |
| A third dose of SARS‐CoV‐2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients AH Karaba, X Zhu, T Liang, KH Wang, AG Rittenhouse, O Akinde, Y Eby, ... American Journal of Transplantation 22 (4), 1253-1260, 2022 | 105 | 2022 |
| Prevalence and durability of SARS-CoV-2 antibodies among unvaccinated US adults by history of COVID-19 JL Alejo, J Mitchell, A Chang, TPY Chiang, AB Massie, DL Segev, ... Jama 327 (11), 1085-1087, 2022 | 77 | 2022 |
| A fourth dose of COVID-19 vaccine does not induce neutralization of the omicron variant among solid organ transplant recipients with suboptimal vaccine response AH Karaba, TS Johnston, TY Aytenfisu, O Akinde, Y Eby, JE Ruff, ... Transplantation 106 (7), 1440-1444, 2022 | 57 | 2022 |
| Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series CM Connolly, TPY Chiang, BJ Boyarsky, JA Ruddy, M Teles, JL Alejo, ... Annals of the rheumatic diseases 81 (2), 293-295, 2022 | 56 | 2022 |
| Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series CM Connolly, M Teles, S Frey, BJ Boyarsky, JL Alejo, WA Werbel, ... Annals of the rheumatic diseases 81 (2), 291-293, 2022 | 49 | 2022 |
| Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series AT Abedon, MS Teles, JL Alejo, JD Kim, J Mitchell, TPY Chiang, RK Avery, ... Transplantation 106 (5), e262-e263, 2022 | 31 | 2022 |
| Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases TPY Chiang, CM Connolly, JA Ruddy, BJ Boyarsky, JL Alejo, WA Werbel, ... Annals of the rheumatic diseases 80 (10), 1365-1366, 2021 | 31 | 2021 |
| Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease S Frey, TPY Chiang, CM Connolly, M Teles, JL Alejo, BJ Boyarsky, ... The Lancet Rheumatology 4 (4), e241-e243, 2022 | 27 | 2022 |
| Experiences obtaining insurance after live kidney donation BJ Boyarsky, AB Massie, JL Alejo, KJ Van Arendonk, S Wildonger, ... American Journal of Transplantation 14 (9), 2168-2172, 2014 | 27 | 2014 |
| Antibody response to a fourth dose of SARS-CoV-2 vaccine in solid organ transplant recipients: an update J Mitchell, JL Alejo, TPY Chiang, J Kim, A Chang, AT Abedon, RK Avery, ... Transplantation 106 (7), e338-e340, 2022 | 26 | 2022 |
| Long-term renal function in living kidney donors who had histological abnormalities at donation LM Fahmy, AB Massie, AD Muzaale, SM Bagnasco, BJ Orandi, JL Alejo, ... Transplantation 100 (6), 1294-1298, 2016 | 25 | 2016 |
| General and acute care surgical procedures in patients with left ventricular assist devices GJ Arnaoutakis, GJ Bittle, JG Allen, ES Weiss, J Alejo, WA Baumgartner, ... World journal of surgery 38 (4), 765-773, 2014 | 22 | 2014 |
| Higher Mortality in registrants with sudden model for end‐stage liver disease increase: Disadvantaged by the current allocation policy AB Massie, X Luo, JL Alejo, AK Poon, AM Cameron, DL Segev Liver Transplantation 21 (5), 683-689, 2015 | 21 | 2015 |
| Omicron BA. 1 and BA. 2 neutralizing activity following pre-exposure prophylaxis with tixagevimab plus cilgavimab in vaccinated solid organ transplant recipients AH Karaba, JD Kim, TPY Chiang, JL Alejo, AT Abedon, J Mitchell, ... MedRxiv, 2022.05. 24.22275467, 2022 | 20 | 2022 |
| Effect of mycophenolate mofetil dosing on antibody response to SARS-CoV-2 vaccination in heart and lung transplant recipients J Mitchell, TPY Chiang, JL Alejo, A Chang, AT Abedon, RK Avery, ... Transplantation 106 (5), e269-e270, 2022 | 19 | 2022 |
| Heterologous Ad. 26. COV2. S versus homologous BNT162b2/mRNA‐1273 as a third dose in solid organ transplant recipients seronegative after two‐dose mRNA vaccination TPY Chiang, JL Alejo, J Mitchell, JD Kim, AT Abedon, AH Karaba, ... American Journal of Transplantation 22 (9), 2254-2260, 2022 | 18 | 2022 |
| Six-month antibody kinetics and durability in SARS-CoV-2 mRNA vaccinated solid organ transplant recipients JL Alejo, J Mitchell, TPY Chiang, AT Abedon, CN Sidoti, BJ Boyarsky, ... Transplantation 106 (1), e109-e110, 2022 | 17 | 2022 |
| Comparison of SARS-CoV-2 antibody response after 2-dose mRNA-1273 vs BNT162b2 vaccines in incrementally immunosuppressed patients J Mitchell, CM Connolly, TPY Chiang, JL Alejo, WA Werbel, DL Segev, ... JAMA Network Open 5 (5), e2211897-e2211897, 2022 | 16 | 2022 |
